Improving portable inhalation therapy through real-time assessment of patient pulmonary state

Nathan A. Berk, Thomas C. Crompton, Peter M. Jansson, John L. Schmalzel

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Metered-dose inhalation therapy is the method of choice for a number of respiratory conditions including asthma and bronchitis. Correct use of the metered-dose inhaler (MDI) has been the subject of much research. Devices have been developed to assist with training in their proper use and to enhance the effectiveness of MDI therapy. However, all lack patient pulmonary state assessment. We have approached the development of an improved portable MDI device by focusing on the total system elements that contribute to a smart inhalation therapy device. Components of such a system should include assessment of the patient's therapeutic state, tracking of drug usage, and also include physician-modified alarm thresholds. Therapeutic state is best assessed with end-expiratory CO2 measurements augmented by inspiratory and expiratory flow efforts. Drug usage monitoring needs to include the time history of drug administration. Physician-modified alarms should allow configuration of the smart inhaler to account for patient condition so that appropriate alarm limits can be established; for example, raising the CO2 alarm threshold for patients with chronic lung disease.

Original languageEnglish (US)
Pages (from-to)503-508
Number of pages6
JournalBiomedical Sciences Instrumentation
Volume33
StatePublished - Dec 1 1997

Fingerprint

Respiratory Therapy
Metered Dose Inhalers
Lung
Nebulizers and Vaporizers
Physicians
Equipment and Supplies
Bronchitis
Drug Monitoring
Pharmaceutical Preparations
Lung Diseases
Chronic Disease
Therapeutics
Asthma
Research

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Medical Laboratory Technology

Cite this

@article{9b0f6aba94924fc6b0209e58c3856a36,
title = "Improving portable inhalation therapy through real-time assessment of patient pulmonary state",
abstract = "Metered-dose inhalation therapy is the method of choice for a number of respiratory conditions including asthma and bronchitis. Correct use of the metered-dose inhaler (MDI) has been the subject of much research. Devices have been developed to assist with training in their proper use and to enhance the effectiveness of MDI therapy. However, all lack patient pulmonary state assessment. We have approached the development of an improved portable MDI device by focusing on the total system elements that contribute to a smart inhalation therapy device. Components of such a system should include assessment of the patient's therapeutic state, tracking of drug usage, and also include physician-modified alarm thresholds. Therapeutic state is best assessed with end-expiratory CO2 measurements augmented by inspiratory and expiratory flow efforts. Drug usage monitoring needs to include the time history of drug administration. Physician-modified alarms should allow configuration of the smart inhaler to account for patient condition so that appropriate alarm limits can be established; for example, raising the CO2 alarm threshold for patients with chronic lung disease.",
author = "Berk, {Nathan A.} and Crompton, {Thomas C.} and Jansson, {Peter M.} and Schmalzel, {John L.}",
year = "1997",
month = "12",
day = "1",
language = "English (US)",
volume = "33",
pages = "503--508",
journal = "Biomedical Sciences Instrumentation",
issn = "0067-8856",
publisher = "ISA - Instrumentation, Systems, and Automation Society",

}

Improving portable inhalation therapy through real-time assessment of patient pulmonary state. / Berk, Nathan A.; Crompton, Thomas C.; Jansson, Peter M.; Schmalzel, John L.

In: Biomedical Sciences Instrumentation, Vol. 33, 01.12.1997, p. 503-508.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Improving portable inhalation therapy through real-time assessment of patient pulmonary state

AU - Berk, Nathan A.

AU - Crompton, Thomas C.

AU - Jansson, Peter M.

AU - Schmalzel, John L.

PY - 1997/12/1

Y1 - 1997/12/1

N2 - Metered-dose inhalation therapy is the method of choice for a number of respiratory conditions including asthma and bronchitis. Correct use of the metered-dose inhaler (MDI) has been the subject of much research. Devices have been developed to assist with training in their proper use and to enhance the effectiveness of MDI therapy. However, all lack patient pulmonary state assessment. We have approached the development of an improved portable MDI device by focusing on the total system elements that contribute to a smart inhalation therapy device. Components of such a system should include assessment of the patient's therapeutic state, tracking of drug usage, and also include physician-modified alarm thresholds. Therapeutic state is best assessed with end-expiratory CO2 measurements augmented by inspiratory and expiratory flow efforts. Drug usage monitoring needs to include the time history of drug administration. Physician-modified alarms should allow configuration of the smart inhaler to account for patient condition so that appropriate alarm limits can be established; for example, raising the CO2 alarm threshold for patients with chronic lung disease.

AB - Metered-dose inhalation therapy is the method of choice for a number of respiratory conditions including asthma and bronchitis. Correct use of the metered-dose inhaler (MDI) has been the subject of much research. Devices have been developed to assist with training in their proper use and to enhance the effectiveness of MDI therapy. However, all lack patient pulmonary state assessment. We have approached the development of an improved portable MDI device by focusing on the total system elements that contribute to a smart inhalation therapy device. Components of such a system should include assessment of the patient's therapeutic state, tracking of drug usage, and also include physician-modified alarm thresholds. Therapeutic state is best assessed with end-expiratory CO2 measurements augmented by inspiratory and expiratory flow efforts. Drug usage monitoring needs to include the time history of drug administration. Physician-modified alarms should allow configuration of the smart inhaler to account for patient condition so that appropriate alarm limits can be established; for example, raising the CO2 alarm threshold for patients with chronic lung disease.

UR - http://www.scopus.com/inward/record.url?scp=0031428422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031428422&partnerID=8YFLogxK

M3 - Article

C2 - 9731411

AN - SCOPUS:0031428422

VL - 33

SP - 503

EP - 508

JO - Biomedical Sciences Instrumentation

JF - Biomedical Sciences Instrumentation

SN - 0067-8856

ER -